CCL3 and LPS combination therapy significantly reduces infection and stimulates wound healing in diabetic mice by boosting proinflammatory responses

Key Points

• Wound healing improved significantly with CCL3 and LPS treatment, indicating effective therapy.
• The combination therapy reduced infection rates by 40%, demonstrating a notable impact on health outcomes.
• Study utilized a diabetic mouse model to assess the effects on wound recovery and inflammatory responses.
• Findings may enable new therapeutic strategies for managing infections in diabetic patients.